⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDGL News
Madrigal Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
MDGL
Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
MEDIA INVITE: A Conversation on Bias and Lived Experience
prnewswire.com
LLY
NVO
BG
AMGN
MDGL
RGP
PFE
REGN
WVE
ZETA
BSX
Madrigal Pharmaceuticals to Release Second-Quarter 2026 Financial Results and Host Webcast on July 30, 2026
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Ribo und Madrigal erreichen ersten wichtigen Meilenstein bei der Weiterentwicklung neuartiger siRNA-Therapien für MASH
prnewswire.com
MDGL
Ribo y Madrigal alcanzan un primer hito importante en el avance de nuevas terapias con siRNA para MASH
prnewswire.com
MDGL
Ribo et Madrigal franchissent une première étape majeure dans le développement de nouvelles thérapies à base d'ARNsi pour la stéatohépatite associée à un dysfonctionnement métabolique (MASH)
prnewswire.com
MDGL